D. P. Lane and L. V. Crawford, T antigen is bound to a host protein in SV40-transformed cells, Nature, vol.278, pp.261-263, 1979.

A. V. Gudkov and E. A. Komarova, Prospective therapeutic applications of p53 inhibitors, Biochem Biophys Res Commun, vol.331, pp.726-736, 2005.

R. Brosh and V. Rotter, When mutants gain new powers: news from the mutant p53 field, Nat Rev Cancer, vol.9, pp.701-713, 2009.

T. M. Kadia, TP53 mutations in newly diagnosed acute myeloid leukemia: Clinicomolecular characteristics, response to therapy, and outcomes, Cancer, 2016.

Y. Cho, S. Gorina, P. D. Jeffrey, and N. P. Pavletich, Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations, Science, vol.265, pp.346-355, 1994.

M. P. Kim and G. Lozano, Mutant p53 partners in crime, Cell Death Differ, vol.25, pp.161-168, 2018.

P. A. Muller, K. H. Vousden, and J. C. Norman, p53 and its mutants in tumor cell migration and invasion, J Cell Biol, vol.192, pp.209-218, 2011.

M. Oren and V. Rotter, Mutant p53 gain-of-function in cancer, Cold Spring Harb Perspect Biol, vol.2, p.1107, 2010.

G. Bougeard, Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families, J Med Genet, vol.45, pp.535-538, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00698382

Y. Zerdoumi, Drastic effect of germline TP53 missense mutations in Li-Fraumeni patients, Hum Mutat, vol.34, pp.453-461, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02329548

Y. A. Suh, Multiple stress signals activate mutant p53 in vivo, Cancer Res, vol.71, pp.7168-7175, 2011.

A. Petitjean, Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database, Hum Mutat, vol.28, pp.622-629, 2007.

K. Yoshikawa, Mutant p53 R248Q but not R248W enhances in vitro invasiveness of human lung cancer NCI-H1299 cells, Biomed Res, vol.31, pp.401-411, 2010.

W. Hanel, N. Marchenko, S. Xu, S. X. Yu, W. Weng et al., Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis, Cell Death Differ, vol.20, pp.898-909, 2013.

S. S. Mello and L. D. Attardi, Not all p53 gain-of-function mutants are created equal, Cell Death Differ, vol.20, pp.855-857, 2013.

J. W. Ng, D. Lama, S. Lukman, D. P. Lane, C. S. Verma et al., R248Q mutation--Beyond p53-DNA binding, Proteins, vol.83, pp.2240-2250, 2015.

A. Bom and A. P. , Mutant p53 aggregates into prion-like amyloid oligomers and fibrils: implications for cancer, J Biol Chem, vol.287, pp.28152-28162, 2012.

S. Peller and V. Rotter, TP53 in hematological cancer: low incidence of mutations with significant clinical relevance, Hum Mutat, vol.21, pp.277-284, 2003.

R. C. Lindsley, Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation, N Engl J Med, vol.376, pp.536-547, 2017.

F. G. Rucker, TP53 alterations in acute myeloid leukemia with complex karyotype correlate with specific copy number alterations, monosomal karyotype, and dismal outcome, Blood, vol.119, pp.2114-2121, 2012.

R. Vijayakumaran, K. H. Tan, P. J. Miranda, S. Haupt, and Y. Haupt, Regulation of Mutant p53 Protein Expression, Front Oncol, vol.5, p.284, 2016.

J. Bartek, R. Iggo, J. Gannon, and D. P. Lane, Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines, Oncogene, vol.5, pp.893-899, 1990.

D. Li, Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells, Mol Cancer Res, vol.9, pp.577-588, 2011.

S. Choudhury, V. K. Kolukula, A. Preet, C. Albanese, and M. L. Avantaggiati, Dissecting the pathways that destabilize mutant p53: the proteasome or autophagy, Cell Cycle, vol.12, pp.1022-1029, 2013.

O. C. Rodriguez, Dietary downregulation of mutant p53 levels via glucose restriction: mechanisms and implications for tumor therapy, Cell Cycle, vol.11, pp.4436-4446, 2012.

H. Vakifahmetoglu-norberg, Chaperone-mediated autophagy degrades mutant p53, Genes Dev, vol.27, pp.1718-1730, 2013.

E. Morselli, Mutant p53 protein localized in the cytoplasm inhibits autophagy, Cell Cycle, vol.7, pp.3056-3061, 2008.

M. Cordani, Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition, Mol Oncol, vol.10, pp.1008-1029, 2016.

N. Allende-vega, The presence of wild type p53 in hematological cancers improves the efficacy of combinational therapy targeting metabolism, Oncotarget, vol.6, pp.19228-19245, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01835529

H. Zhang and F. Burrows, Targeting multiple signal transduction pathways through inhibition of Hsp90, J Mol Med, vol.82, pp.488-499, 2004.

M. Riedel, O. Goldbaum, L. Schwarz, S. Schmitt, and C. Richter-landsberg, 17-AAG induces cytoplasmic alpha-synuclein aggregate clearance by induction of autophagy, PLoS One, vol.5, p.8753, 2010.

L. Neckers and K. Neckers, Heat-shock protein 90 inhibitors as novel cancer chemotherapeutic agents, Expert Opin Emerg Drugs, vol.7, pp.277-288, 2002.

A. Khan, Human Leukemic Cells performing Oxidative Phosphorylation (OXPHOS) Generate an Antioxidant Response Independently of Reactive Oxygen species (ROS) Production, EBioMedicine, vol.3, pp.43-53, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01877446

A. Khan, Mitochondrial Complex I activity signals antioxidant response through ERK5, Scientific reports, vol.8, p.7420, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01835615

A. Khan, The PDK1 Inhibitor Dichloroacetate Controls Cholesterol Homeostasis Through the ERK5/MEF2 Pathway, Scientific reports, vol.7, p.10654, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01835605

L. Whitesell and S. L. Lindquist, HSP90 and the chaperoning of cancer, Nat Rev Cancer, vol.5, pp.761-772, 2005.

E. Viry, Autophagy: an adaptive metabolic response to stress shaping the antitumor immunity, Biochem Pharmacol, vol.92, pp.31-42, 2014.

L. Galluzzi, Autophagy in malignant transformation and cancer progression, EMBO J, vol.34, pp.856-880, 2015.

E. Tasdemir, Regulation of autophagy by cytoplasmic p53, Nat Cell Biol, vol.10, pp.676-687, 2008.

E. Morselli, p53 inhibits autophagy by interacting with the human ortholog of yeast Atg17, RB1CC1/FIP200, Cell Cycle, vol.10, pp.2763-2769, 2011.

S. Y. Han, Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF, Cancer Res, vol.77, pp.343-354, 2017.

H. L. Chiang, S. R. Terlecky, C. P. Plant, and J. F. Dice, A role for a 70-kilodalton heat shock protein in lysosomal degradation of intracellular proteins, Science, vol.246, pp.382-385, 1989.

R. Kang, H. J. Zeh, M. T. Lotze, and D. Tang, The Beclin 1 network regulates autophagy and apoptosis, Cell Death Differ, vol.18, pp.571-580, 2011.

I. Tasset and A. M. Cuervo, Role of chaperone-mediated autophagy in metabolism, The FEBS journal, vol.283, pp.2403-2413, 2016.

U. Bandyopadhyay, S. Kaushik, L. Varticovski, and A. M. Cuervo, The chaperonemediated autophagy receptor organizes in dynamic protein complexes at the lysosomal membrane, Mol Cell Biol, vol.28, pp.5747-5763, 2008.

S. Akakura, M. Yoshida, Y. Yoneda, and S. Horinouchi, A role for Hsc70 in regulating nucleocytoplasmic transport of a temperature-sensitive p53 (p53Val-135), J Biol Chem, vol.276, pp.14649-14657, 2001.

S. Shen, Cyclodepsipeptide toxin promotes the degradation of Hsp90 client proteins through chaperone-mediated autophagy, J Cell Biol, vol.185, pp.629-639, 2009.

A. C. Massey, S. Kaushik, G. Sovak, R. Kiffin, and A. M. Cuervo, Consequences of the selective blockage of chaperone-mediated autophagy, Proc Natl Acad Sci U S A, vol.103, pp.5805-5810, 2006.

H. Wu, Crosstalk Between Macroautophagy and Chaperone-Mediated Autophagy: Implications for the Treatment of Neurological Diseases, Mol Neurobiol, vol.52, pp.1284-1296, 2014.

F. Boschelli, A cell-based screen for inhibitors of protein folding and degradation, Cell Stress Chaperones, vol.15, pp.913-927, 2010.

N. Allende-vega, A. Sparks, D. P. Lane, and M. K. Saville, MdmX is a substrate for the deubiquitinating enzyme USP2a, Oncogene, vol.29, pp.432-441, 2010.

R. Scherz-shouval, H. Weidberg, C. Gonen, S. Wilder, Z. Elazar et al., p53-dependent regulation of autophagy protein LC3 supports cancer cell survival under prolonged starvation, Proc Natl Acad Sci U S A, vol.107, pp.18511-18516, 2010.